baber/WOPTO huggingface dataset:
Patent EP-1199804-A2 (EP)
Inventor: NOGUCHI HIDEMI
IPC: H04L7/033
Filed: 2001-10-15
Abstract: The invention includes a first flip-flop (FF) 2 for
taking in a clock signal CLK output of a voltage control
oscillator 1 at a leading or trailing edge of a data signal to
then output it, a delay circuit 3 for delaying the clock signal
output of the voltage control oscillator by 90° a second FF4
for taking in the clock signal delayed at the delay circuit 3
at leading or trailing transition timing of the data signal to
then output it, a logical product circuit 5 for AND'ing an
output of the second FF and the clock signal CLK90 delayed by
the delay circuit, a third FF6 for taking in an output of the
first FF at leading or trailing transition timing of an output
of the logical product circuit 5 to then output it, and an
average detector circuit 7 for detecting a time-wise average
of an output of the third FF6, an output voltage of which circuit
7 is fed back to a control terminal of the voltage control
oscillator.
Patent EP-1205846-A2 (EP)
Inventor: BRACHERT JOST
IPC: H03M7/24
Filed: 2001-11-07
Abstract: Die Erfindung betrifft ein Verfahren und eine Vorrichtung zur automatischen Wandlung eines arithmetischen Ausdrucks in Gleitkomma-Arithmetik in einen entsprechenden arithmetischen Ausdruck in Festkomma-Arithmetik. Dabei werden Normierungsfaktoren (c_y, c_t1, c_t2) für eine Normierung von Variablen (y, t1, t2) des Gleitkomma-Ausdrucks bestimmt und die normierten Variablen (Y, T1, T2) in den Gleitkomma-Ausdruck eingesetzt. Um einen Festkomma-Ausdruck mit einem möglichst kompakten Programmcode und einer möglichst kurzen Laufzeit generieren zu können wird vorgeschlagen, dass die Normierungsfaktoren (c_y, c_t1, c_t2) durch Multiplikation und/oder Division so weit zu Konstanten (k1, k2, k) zusammengefasst werden, dass die Anzahl der Konstanten (k1, k2, k) minimiert wird. Es werden außerdem Optimierungsalgorithmen vorgeschlagen, durch die die Anzahl der zur Ausführung des Festkomma-Ausdrucks abzuarbeitenden Operationen weiter reduziert werden kann.
Patent EP-1211795-A2 (EP)
Inventor: ROSE ROBERT E SR
IPC: H02M7/00
Filed: 2001-11-27
Abstract: The invention provides a bridge assembly for a three-phase motor. The assembly
includes a first subassembly having a first terminal plate, a second subassembly having a
second terminal plate, a third subassembly having a third terminal plate and a fourth
subassembly having a bus terminal plate. Each of the terminal plates is electrically
isolated from the other terminal plates, and at least one of the first, second, third and bus
terminal plates acts as a heat sink. The assembly further includes first, second, third,
fourth, fifth and sixth switching devices interconnected to at least one of the terminal
plates. Each switching device has a heat generating surface in thermal communication
with one of the first, second, third and bus terminal plates. The assembly further includes
a fifth subassembly interconnected with the first, second, third, and fourth subassemblies.
Patent EP-1229289-A2 (EP)
Inventor: SYMANOWSKI CHRISTFRIED
IPC: G02B27/09
Filed: 2001-12-19
Abstract: The device has a light mixing rod (2) of quadrilateral cross-section with a quadrilateral light input surface (7) and a quadrilateral outlet surface (8) between which it passes light to produce the illuminated rectangular field. The outlet surface is bounded by 4 straight lines, of which each two intersect at one of the corner points. The sides incident at a corner point intersect at 90 degrees.   Independent claims are also included for the following: the use of an arrangement for producing a rectangular illuminated field for an optical arrangement.
Patent EP-1223672-A2 (EP)
Inventor: ISHIYAMA HIDESHI
IPC: H01H9/54
Filed: 2001-12-27
Abstract: An electronic device (100) does not carry out
control operation corresponding to a signal (Sh, Se) from
an operation button which is kept in pressed state when
electric power (30) is supplied. When electric power (30)
is supplied, the voltage changing depending on open and
closed state of switches (SW1 - SW4) corresponding to
operation buttons to be manipulated is judged to be a
specified value or not. When the voltage is not judged
to be specified value, the control unit (10e) does not carry
out control operation corresponding to the signal from the
operation button that has been in pressed state.
Patent EP-1148374-A2 (EP)
Inventor: FUKUMOTO YOSHIHIKO
IPC: H01L29/786
Filed: 1996-06-28
Abstract: An active matrix substrate includes, on a substrate, a
plurality of switching elements using a silicon layer,
and a conductive member having a substantially even
surface and constituting a plurality of pixels. An
insulating member containing a silicon atom is disposed
at an end of said conductive member substantially
continuous with said even surface.
Patent EP-1210919-A2 (EP)
Inventor: AMPLATZ CURTIS
IPC: A61F2/01
Filed: 1995-07-10
Abstract: Medical device for occluding an opening in a vascular system formed
from a metal fabric having a plurality of metal strands. Clamps are affixed to
the ends of the metal strands. Stretching the device reduces the cross-sectional
dimension of the device for deployment through a catheter. When
the constraining force is removed, the device returns to its pre-set shape. A
method of forming a device from a metal fabric formed of a plurality of strands
includes the steps of conforming the fabric to a surface, defining an expanded
configuration of the device in which the relative position of the strands is re-orientated.
These strands are set in the re-orientated positions before
removal of the moulding element.
Patent EP-1339426-A2 (EP)
Inventor: SALCEDO THEODORA
IPC: C07K16/28
Filed: 2001-11-07
Abstract: L'invention concerne des anticorps et des molécules connexes à liaison immunospécifique avec les récepteurs TRAIL. Ces anticorps sont utiles, par exemple, dans la prévention et le traitement du cancer et autres troubles proliférants. L'invention concerne également des molécules d'acides nucléiques codant des anticorps vis-à-vis des récepteurs TRAIL, des vecteurs et des cellules hôtes renfermant ces acides nucléiques, et des procédés relatifs à leur élaboration. L'invention concerne en outre des procédés et des compositions pour la prévention, la détection, le diagnostic, le traitement ou l'amélioration d'une maladie ou d'un trouble, en particulier le cancer et autres troubles hyperproliférants: on administre à un animal, de préférence un être humain, une quantité efficace d'un ou plusieurs anticorps ou bien de fragments ou de variants correspondants, ou encore des molécules connexes, à capacité de liaison spécifique avec le récepteur TRAIL.
Patent EP-1119026-A2 (EP)
Inventor: KUIBIRA AKIRA
IPC: H01L21/205
Filed: 2001-01-19
Abstract: A wafer holder (10) is configured of a pair of
ceramic base members (4) and conductive layers (1, 2,
3) each posed between the ceramic base members. The
conductive layer (1, 2, 3) has a body (1A, 2A, 3A)
facing a wafer (20) and an extraction (1B, 2B, 3B,)
extracted from the body for external connection,
wherein the body (1A, 2A, 3A) and the extraction (1B,
2B, 3B) are arranged in a single plane. Thus there
can be obtained a wafer holder for use with a
semiconductor manufacturing apparatus that can reduce
such distortion as caused when it is heated and cooled
and that can also be readily manufactured.
Patent EP-1154247-A2 (EP)
Inventor: BERG BERNARD J
IPC: G01N21/21
Filed: 2001-05-04
Abstract: A color measurement instrument capable of measuring both the nonpolarized
spectral response and the polarized spectral response of a sample (5) on a single reading. The
instrument includes a source of polarized light (12,14) to illuminate the sample (5), and a
detector (18) for measuring the light reflected by the sample. A rotatable filter wheel (16) is
located between the sample (5) and the detector (18). Nonpolarizing bandpass filters (22) and
polarizing bandpass filters (20) are mounted in the wheel (16) in a circular configuration. A
drive mechanism rotates the wheel (16) to automatically sequentially align each of the
nonpolarizing filters (22) and the polarizing filters (20) with the detector (18), enabling the
instrument to sample both nonpolarized data and polarized data on a single reading.
Patent EP-1187302-A2 (EP)
Inventor: SAKAMOTO MASAFUMI
IPC: H02K19/10
Filed: 2001-07-26
Abstract: There is provided a motor-driven system (10) which realizes an
optimum driving mode for an electric automobile, a robot carrier
car, a drum of a copying machine, etc., and a motor-driven system
having a function as an optimum actuator for such driving. In a
rotational electric machine provided with a stator (62) and an outer
rotor type permanent magnet rotor (52), the stator having an annular
magnetic substance, main poles (A1-C2) provided so as to extend
radially outward from the annular magnetic substance, windings (61)
wound on the main poles respectively, and inductors each constituted
by a plurality of magnetic teeth formed at a forward end of
corresponding one of the main poles (A1-C2), the rotor having north
(N) and south (S) magnetic poles arranged alternately on an inner
circumference of the rotor and in a rotating direction of the rotor,
the stator (62) and the rotor (52) being in opposition to each other
while an air gap is held therebetween, there is provided a motor-driven
system in which an outer rotating body (50) such as a tire, a
drum, a table or the like is mounted on an outer circumferential
portion or on a side portion of the rotor.
Patent EP-1180389-A2 (EP)
Inventor: JAIN RAVI
IPC: B01D53/81
Filed: 2001-07-27
Abstract: In a process for removing nitrogen oxides from gas streams such as furnace or utility
boiler flue gas stream an adsorber system C is used to adsorb nitrogen oxides from
the flue gas streams. An oxygen/ozone gas stream 7 contacts the adsorbed
nitrogen oxides to convert the nitrogen oxides to N 2 O 5  which exits the adsorber C as
stream 5 with the oxygen stream. The stream 5 is typically treated in a scrubber D.
Patent EP-1205156-A2 (EP)
Inventor: PONZI DEAN M
IPC: A61B18/14
Filed: 2001-11-13
Abstract: An injection catheter for infusing therapeutic and diagnostic agents into the heart is
provided. The injection catheter comprises a catheter body comprising a flexible tubing having
proximal and distal ends and at least one lumen therethrough. A tip section comprising a flexible
tubing having proximal and distal ends is mounted at the distal end of the catheter body. A
needle control handle is provided at the proximal end of the catheter body. An injection needle
extends through the tip section, catheter body, and needle control handle and has a proximal end
attached to the needle control handle and a distal end within the tip section. The injection needle
is longitudinally slidable within the tip section so that its distal end can extend beyond the distal
end of the tip section upon suitable manipulation of the needle control handle. The catheter
further comprises an electrode lead wire having a first end electrically connected to the injection
needle and a second end electrically connected to a suitable monitoring apparatus or to a source
of ablation energy. The injection needle can thus be used for mapping or ablation in addition to
introducing therapeutic and diagnostic agents into the heart.
Patent EP-1219332-A2 (EP)
Inventor: KURODA KAZUO
IPC: A63F13/79
Filed: 2001-12-07
Abstract: A network game system for operating on a network a game
made up of basic content containing a basic program for executing
start of a game solely and one or more types of relevant content
each containing a relevant program corresponding to the basic
program for further advancing the game started by the basic
program. The system includes a content management section
adapted to set an address of which users are not notified in
one or more content providing servers each in which the relevant
program is placed, the address for which a search is made by
search means on the network from a user terminal; wherein the
content providing server sends the relevant content placed in
the content providing server to the user terminal in response
to a download request made by the accessing user.
Patent EP-1193871-A2 (EP)
Inventor: KOJI HIRAIRI
IPC: H03K3/3562
Filed: 2001-09-27
Abstract: A latch and a D-type flip-flop capable of
realizing high speed operation and capable of achieving
a reduction of power consumption, wherein in a master
side latch, a first NMOS transistor (NT116) always in
the ON state is provided as a first parallel resistor
means connected in parallel with a second NMOS
transistor (NT113) (servicing as the first input
discriminating means) receiving a data input signal D,
and a third NMOS transistor (NT117) always in the ON
state is provided as a second parallel resistor means
connected in parallel with a fourth NMOS transistor
(NT114) (servicing as the second input discriminating
means) receiving an inverted data input signal (DX). 
     By this, without enlarging the transistor sizes of
the second and fourth NMOS transistors, an equivalent
combined resistance of discharge paths can be reduced
by these parallel resistor means, a high speed
operation can be realized, and a lowering of a power
consumption can be realized.
Patent EP-1122291-A2 (EP)
Inventor: MITZI DAVID BRIAN
IPC: H01L21/316
Filed: 2001-01-11
Abstract: An organic-inorganic perovskite having alternating layers
of an inorganic anion layer and an organic cation layer is
provided. More particularly, the inorganic anion layer of the
organic-inorganic perovskite has a trivalent or higher valent
metal halide framework and the organic cation layer has a
plurality of organic cations capable of templating the
metal-deficient inorganic anion layers within the perovskite
structure.A typical organic-inorganic perovskite compound has a
formula such as (Disprotonated AEQT) Bi 2/3  I 4 , wherein AEQT is
5,5'''-bis(aminoethyl)-2,2':5',2'':5'',2'''-quaterthiophene
Methods of preparing the organic-inorganic perovskite according
to the present invention are also provided.
Patent EP-1196076-A2 (EP)
Inventor: FRANK WILLIAM F
IPC: G06F9/46
Filed: 2001-02-02
Abstract: L'invention concerne un procédé servant à structurer des communications entre des éléments de logiciel en fonction d'événements vocaux représentés par ces communications, ainsi qu'un procédé servant à répondre à ces communications. Le procédé de structuration des communications consiste à utiliser un ensemble d'événements de communication prédéfinis, représentant chacun un type d'action et classifiés selon l'effet attendu sur un composant récepteur. Quand il est nécessaire qu'un premier composant de logiciel communique avec un autre composant ou plusieurs composants de logiciel, un acte de communication est sélectionné, cet acte représentant le besoin de l'ensemble d'événements de communication prédéfinis. La communication est construite de façon à inclure cet événement de communication sélectionné et un argument définissant un sujet de l'acte de communication. Le composant ou les composants de logiciel auxquels la communication devrait être adressée, sont déterminés et la communication est dirigée vers ce ou ces composants. Le procédé de réponse à la communication consiste à interpréter cette communication afin de déterminer l'action qu'un composant de logiciel récepteur doit exercer en réponse à la communication. L'interprétation de la communication consiste à identifier l'acte de communication, à déterminer un ensemble standard de réponse associé à l'acte de communication et à sélectionner une réponse correcte dans cet ensemble en fonction du contexte de la communication.
Patent EP-1250434-A2 (EP)
Inventor: JAKOBOVITS AYA
IPC: C12N15/113
Filed: 2001-01-26
Abstract: A novel gene (designated 84P2A9) and its encoded protein is described. While 84P2A9 exhibits prostate and testis specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, testis, kidney, brain, bone, skin, ovarian, breast, pancreas, colon, lymphocytic and lung cancers. Consequently, 84P2A9 provides a diagnostic and/or therapeutic target for cancers, and the 84P2A9 gene or fragment thcrcof, or its encoded protein or a fragment thereof used to elicit an immune response.
Patent EP-1272527-A2 (EP)
Inventor: BELIARD ROLAND
IPC: A61P35/00
Filed: 2001-04-12
Abstract: Preparation (M1) of monoclonal antibodies (MAb) that activate effector cells expressing Fcgamma RIII (A). Preparation (M1) of monoclonal antibodies (MAb) that activate effector cells expressing Fcgamma RIII (A). Monoclonal antibodies expressed from different clones, derived from selected hybridomas (especially heterohybridomas) or animal or human cells transfected with a vector containing a gene for an antibody, are purified, then incubated with a mixture containing target cells, effector cells expressing (A), and polyvalent immunoglobulin G (IgG). Those MAb that produce significant lysis of target cells (by induction of (A)-type antibody-dependent cellular cytotoxicity (ADCC)) are chosen. Independent claims are also included for the following: (1) MAb produced by (M1), having type-(A) ADCC over 60%, especially 90% of that for reference polyclonal antibodies; (2) any MAb directed against a particular antigen and able to activate effector cells to provide type-(A) ADCC over 60, especially 90% of that for reference polyclonal antibodies; (3) MAb that have, on the glycosylation site at Asn297 of Fcgamma , two-branched glycosylation structures with short arms, low degree of silylation and terminal mannose residues and/or non-intercalating N-acetylglucosamine (GlcNAc); (4) cells that produce MAb; (5) pharmaceutical composition containing MAb; and (6) diagnostic composition containing MAb. ACTIVITY : Antibacterial; antiviral; cytostatic; hemostatic; immunostimulant. MECHANISM OF ACTION : Antibody-dependent cellular cytotoxicity inducer.
Patent EP-1286672-A2 (EP)
Title: S-methyl-dihydro-ziprasidone utilise dans le traitement des troubles psychiatriques et oculaires
Inventor: PRAKASH CHANDRA A
IPC: A61K31/496
Filed: 2001-05-28
Abstract: La présente invention concerne des compositions pharmaceutiques contenant S-méthyl-dihydroziprasidone ainsi que l'utilisation de ce composé et de ses sels acceptables sur le plan pharmaceutique dans le traitement des troubles psychiatriques et oculaires. Plus particulièrement, cette invention concerne l'utilisation de ce composé et de ses sels acceptables sur le plan pharmaceutique pour le traitement d'un trouble ou d'un état pathologique tels que: schizophrénie, anxiété, notamment le trouble d'anxiété généralisée, le trouble panique, le trouble de stress post-traumatique et les phobies (par exemple, la phobie sociale, l'agoraphobie, etc.); d'épisodes psychotiques de l'anxiété: anxiété, agitation, agressivité excessive, tension, retrait social ou affectif associé à la psychose; de troubles psychotiques de l'humeur, tel que le trouble dépressif majeur grave; de troubles de l'humeur associés à des troubles psychotiques tels que la manie aiguë et la dépression associées à un trouble bipolaire, et les troubles de l'humeur associés à la schizophrénie; de troubles du comportement associés à une déficience mentale, à un trouble auditif, et à un trouble de la conduite; de démences, notamment celles associées à la maladie d'Alzheimer; de la dyskinésie d'origine médicamenteuse et neurodégénérative; de troubles compulsifs obsessionnels; du syndrome de Tourette; du glaucome; et de la rétinopathie ischémique.
Patent EP-1303625-A2 (EP)
Inventor: HEDLEY MARY LYNNE
IPC: C07H21/04
Filed: 2001-07-16
Abstract: Cette invention a trait à des polypeptides contenant α-MSH pouvant être utilisés pour traiter des états pathologiques caractérisés par ne inflammation et/ou une auto-immunité. Elle porte également sur des analogues de α-MSH ainsi que sur des acides nucléiques codant des polypeptides contenant α-MSH et sur des analogues de α-MSH éventuellement liés à des séquences hétérologues. Elle concerne, en outre des méthodes d'administration de peptides contenant analogues de α-MSH, des analogues de analogues de α-MSH et de l'ADN codant analogues de α-MSH et des analogues de α-MSH.
Patent EP-1360319-A2 (EP)
Inventor: OLEK ALEXANDER
IPC: A61K31/711
Filed: 2001-04-06
Abstract: The present invention relates to the chemically modified genomic sequences of genes associated with DNA transcription, to oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA transcription which are directed against the sequence, as well as to a method for ascertaining genetic and/or epigenetic parameters of genes associated with DNA transcription.
Patent EP-1311930-A2 (EP)
Inventor: BYRNE BARRY ANTHONY
IPC: C07K14/435
Filed: 2001-08-03
Abstract: A method and system for automatically and transparently providing access to resources associated with a web server which requires authentication. A server is provided for a web browser, which intercepts and responds to authentication requests from web servers. The method and system allows a user to access multiple network resources with a single initial authentication procedure.
Patent EP-1307264-A2 (EP)
Inventor: BARBIER PIERRE
IPC: A61K31/365
Filed: 2001-07-19
Abstract: L'invention concerne des combinaisons pharmaceutiques, des compositions et des traitements de l'obésité. L'invention se réfère plus particulièrement trait à une combinaison ou à une composition contenant un inhibiteur de lipase, de préférence un orlistat et un agent séquestrant d'acides biliaires.
Patent EP-1316204-A2 (EP)
Inventor: VAN ZON CORNELIS
IPC: H04N7/50
Filed: 2001-08-17
Abstract: L'invention concerne un appareil de commande de la charge de traitement d'un décodeur de vidéo modulable décodant un train de bits de vidéo modulable entrant et générant un signal vidéo de bande de base. L'appareil comprend: 1) un contrôleur universel destiné à mesurer au moins une caractéristique dudit train et générant au moins un paramètre de vidéo associé à la caractéristique; et 2) une unité de commande de la charge d'un processeur permettant de recevoir ledit paramètre et, en réponse à celui-ci, de commander un niveau de décodage du train de bits de vidéo modulable entrant effectué par le décodeur vidéo modulable.
Patent EP-1311620-A2 (EP)
Inventor: ACHILLE FELIX
IPC: A61F13/49
Filed: 2001-07-11
Abstract: An extrudable thermoplastic superabsorbent polymer blend composition is disclosed. The blend compositions are especially well suited for preparation of extruded or molded articles such as monolayer films, multilayer films, nonwoven webs, sheets, foams, profiles, multilayer laminates, fibers, tubes, rods or pipes which in turn are well suited for preparation of power and communication cables or disposable absorbent articles such as diapers, sanitary napkins, tampons, incontinence products, hospital gowns or bed pads.
Patent EP-1338013-A2 (EP)
Inventor: MUELLER DETLEF
IPC: G06F15/78
Filed: 2001-11-14
Abstract: A circuit arrangement, particularly for electronically processing and/or storing digital signals, the circuit arrangement comprising at least one programmable switching device (referred to as 'fuse') for permanently switching off predetermined parts of the circuit arrangement, at least one of the fuses having a multistage structure.  This provides a measure allowing both a versatile and modifiable prototype construction and a possibly simple and reliable production of the corresponding derivatives.